Clinical policies aim to prevent avoidable harm to patients by only offering treatments on the NHS that are evidence-based, clinically safe and effective, as well as cost effective and a good use of resources.
There is not currently a single clinical policy for familial breast cancer that applies to people across the whole Central East area.
Where a predecessor Integrated Care Board (ICB) had an agreed clinical policy on familial breast reconstruction cancer, this policy transferred to Central East ICB on 1 April 2026. Previously agreed policies will continue to apply just to people living in that former ICB’s area until any new policy is adopted by NHS Central East ICB.
Where an area doesn’t have a previously agreed policy on familial breast cancer, support for patients in that area will be based on a routine commissioning pathway.
Local clinical policy positions for familial breast cancer
Bedfordshire, Luton and Milton Keynes
No Policy (Routine Commissioning Pathway)
Cambridgeshire and Peterborough
Hertfordshire and West Essex
No Policy (Routine Commissioning Pathway)